The Gentles lab at Stanford University has postdoc positions available for several projects in analyzing genomic and proteomic data in cancer using systems biology approaches. Our works spans multiple cancer types, using a combination of computational and experimental methods to address questions in tumor biology with a particular interest in the content and organization of the tumor microenvironment, and its influence on patient outcomes and therapy response. As one example, we are interested in understanding immunotherapy response in a rare cancer type called clear cell ovarian cancer.
Opportunities are available for outstanding candidates to join a highly innovative project team developing a new understanding of mucosal immunity. You will build on our discovery of novel molecule mechanisms of lung and airway lymphocyte homing with relevance to autoimmune disease, asthma and infection. Projects involve state of the art cytometry, scRNAseq and genetic approaches, development of therapeutics and studies of both human and animal models of disease. The successful candidate will have a record of productivity and a demonstrated drive to succeed.
Dr. Cong's group is developing novel technology for genome editing and single-cell genomics, leveraging scalable methods inspired by data science and machine learning and artificial intelligence.
Environmental microbiology (e.g. diatoms, algae) and synthetic biology
Topics: Nitrogen fixation, lipid biosynthesis and transprot, cellular endosymbiosis, nonmodel organisms
Application areas: Fertilizers, Biofuels
Research in the Pollack lab centers on translational genomics, with a current focus on diseases of the prostate. The lab employs next-generation sequencing, single-cell genomics, genome editing, and cell/tissue-based modeling to uncover disease mechanisms, biomarkers and therapeutic targets.
One of the key ways that the gut microbiome impacts human health is through the production of bioactive metabolites. By understanding how microbes produce these molecules, we aim to develop new approaches to promote human health and treat disease. Our laboratory employs bacterial genetics, metabolomics, and gnotobiotic mouse colonization to uncover the chemistry that underlies host-microbe interactions in the gut.
The Schuele lab works on gene discovery and novel stem cell technologies to generate stem cell models from patients with Parkinson’s disease and related disorders to understand the underlying causes of neurodegeneration. Our projects range from clinical genetic family studies and human stem cell modeling of neurocircuits to translational pre-clinical gene therapy studies in Parkinson’s disease.